Search results for:
idarucizumab
idarucizumab
Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
Idarucizumab |
SOLUTION, INTRAVENOUS |
50 mg/mL (50 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Apr. 18, 2023
UNC Health
Emergent Anticoagulation Reversal Guideline
Johnston
Anticoagulant Reversal and Bleeding Management Policy - Praxbind
Lenoir
Anticoagulation Reversal Guideline
Med Center
UNC Medical Center Formulary Restrictions
Rex
Anticoagulant Reversal Guideline